Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RYTM

Rhythm Pharmaceuticals (RYTM)

Rhythm Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RYTM
DateTimeSourceHeadlineSymbolCompany
01/10/20256:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
01/10/20256:15AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming MilestonesNASDAQ:RYTMRhythm Pharmaceuticals Inc
12/20/20241:15PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years OldNASDAQ:RYTMRhythm Pharmaceuticals Inc
12/03/20245:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to inclNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/18/20246:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with SetmelanotideNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/13/20248:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/13/20248:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/13/20248:01PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:RYTMRhythm Pharmaceuticals Inc
11/13/20245:30PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & EndocrinologyNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/13/20243:01PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/12/20246:55AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/08/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/07/20243:36PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/06/20244:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/06/20247:20AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RYTMRhythm Pharmaceuticals Inc
11/06/20247:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation in Upcoming Investor ConferencesNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/05/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/05/20243:01PMGlobeNewswire Inc.Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/04/20243:01PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024NASDAQ:RYTMRhythm Pharmaceuticals Inc
10/24/20245:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl SyndromeNASDAQ:RYTMRhythm Pharmaceuticals Inc
10/23/20247:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024NASDAQ:RYTMRhythm Pharmaceuticals Inc
10/08/20243:01PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
09/19/20243:49PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
09/16/20243:01PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
09/11/20243:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
08/28/20243:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
08/26/20243:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
08/26/20247:02AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years oldNASDAQ:RYTMRhythm Pharmaceuticals Inc
08/26/20247:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in SeptemberNASDAQ:RYTMRhythm Pharmaceuticals Inc
08/14/20243:06PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:RYTMRhythm Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RYTM

Your Recent History

Delayed Upgrade Clock